Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cue Biopharma, Inc. (CUE) had Free Cash Flow per Share of $-2.30 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$5.69M |
|
$-5.18M |
|
-- |
|
$5.69M |
|
$11.04M |
|
$-5.35M |
|
$0.17M |
|
$-5.18M |
|
$-5.18M |
|
$-5.18M |
|
$-5.18M |
|
$-5.18M |
|
$-5.18M |
|
$-5.35M |
|
$-4.79M |
|
4.81M |
|
4.81M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$26.39M |
|
$0.29M |
|
$4.49M |
|
$30.88M |
|
$7.39M |
|
-- |
|
$1.88M |
|
$9.27M |
|
$21.61M |
|
$21.61M |
|
$21.61M |
|
3.25M |
|
| Cash Flow Statement Financials | |
$-10.94M |
|
$-0.12M |
|
$0.31M |
|
$27.29M |
|
$16.53M |
|
$-10.76M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-94.14% |
|
-94.14% |
|
-- |
|
-91.07% |
|
-91.07% |
|
$-11.06M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-- |
|
1.06 |
|
84.70 |
|
-23.96% |
|
-23.96% |
|
-16.77% |
|
-23.96% |
|
$6.64 |
|
|
Free Cash Flow per Share |
$-2.30 |
$-2.28 |
|